ASTERA LABS INC Financials

ALAB

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Financial Profile 80/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

ASTERA LABS INC has an operating margin of -29.3%, meaning the company retains $-29 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -25.5% the prior year.

Growth

100

ASTERA LABS INC's revenue surged 242.2% year-over-year to $396.3M, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

100

ASTERA LABS INC carries a low D/E ratio of 0.09, meaning only $0.09 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 11.71, ASTERA LABS INC holds $11.71 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

100

ASTERA LABS INC converts 25.9% of revenue into free cash flow ($102.4M). This strong cash generation earns a score of 100/100.

Piotroski F-Score Neutral

5/9

ASTERA LABS INC passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-1.64x

For every $1 of reported earnings, ASTERA LABS INC generates $-1.64 in operating cash flow ($136.7M OCF vs -$83.4M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

This page shows ASTERA LABS INC (ALAB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$396.3M

YoY+242.2%

ASTERA LABS INC generated $396.3M in revenue in fiscal year 2024. This represents an increase of 242.2% from the prior year.

EBITDA

-$112.9M

YoY-307.4%

ASTERA LABS INC's EBITDA was -$112.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 307.4% from the prior year.

Free Cash Flow

$102.4M

YoY+761.8%

ASTERA LABS INC generated $102.4M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 761.8% from the prior year.

Net Income

-$83.4M

YoY-217.7%

ASTERA LABS INC reported -$83.4M in net income in fiscal year 2024. This represents a decrease of 217.7% from the prior year.

EPS (Diluted)

$-0.64

YoY+9.9%

ASTERA LABS INC earned $-0.64 per diluted share (EPS) in fiscal year 2024. This represents an increase of 9.9% from the prior year.

Cash & Debt

$79.6M

YoY+76.4%

ASTERA LABS INC held $79.6M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

162M

YoY+285.7%

ASTERA LABS INC had 162M shares outstanding in fiscal year 2024. This represents an increase of 285.7% from the prior year.

Gross Margin

76.4%

YoY+7.4pp

ASTERA LABS INC's gross margin was 76.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 7.4 percentage points from the prior year.

Operating Margin

-29.3%

YoY-3.8pp

ASTERA LABS INC's operating margin was -29.3% in fiscal year 2024, reflecting core business profitability. This is down 3.8 percentage points from the prior year.

Net Margin

-21.1%

YoY+1.6pp

ASTERA LABS INC's net profit margin was -21.1% in fiscal year 2024, showing the share of revenue converted to profit. This is up 1.6 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

$200.8M

YoY+173.6%

ASTERA LABS INC invested $200.8M in research and development in fiscal year 2024. This represents an increase of 173.6% from the prior year.

Share Buybacks

$1.1M

YoY+407.6%

ASTERA LABS INC spent $1.1M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 407.6% from the prior year.

Capital Expenditures

$34.2M

YoY+1140.3%

ASTERA LABS INC invested $34.2M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 1140.3% from the prior year.

ALAB Income Statement

Metric	FY24	FY23	FY22
Revenue	$396.3M+242.2%	$115.8M+45.0%	$79.9M
Cost of Revenue	$93.6M+160.2%	$36.0M+69.7%	$21.2M
Gross Profit	$302.7M+279.2%	$79.8M+36.0%	$58.7M
R&D Expenses	$200.8M+173.6%	$73.4M-0.4%	$73.7M
SG&A Expenses	$94.3M+492.0%	$15.9M-23.3%	$20.8M
Operating Income	-$116.1M-293.5%	-$29.5M+51.0%	-$60.2M
Interest Expense	N/A	N/A	N/A
Income Tax	$1.6M-50.3%	$3.3M+333.1%	$764K
Net Income	-$83.4M-217.7%	-$26.3M+55.0%	-$58.3M
EPS (Diluted)	$-0.64+9.9%	$-0.71+58.5%	$-1.71

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$230.6M+20.1%	$191.9M+20.4%	$159.4M+13.0%	$141.1M+83.6%	$76.8M+17.8%	$65.3M+29.2%	$50.5M+36.8%	$36.9M
Cost of Revenue	$54.8M+18.1%	$46.4M+15.8%	$40.0M+9.2%	$36.6M+115.6%	$17.0M+15.3%	$14.7M+28.3%	$11.5M+30.2%	$8.8M
Gross Profit	$175.8M+20.8%	$145.6M+21.9%	$119.4M+14.3%	$104.4M+74.5%	$59.9M+18.5%	$50.5M+29.5%	$39.0M+38.9%	$28.1M
R&D Expenses	$78.9M+18.3%	$66.7M+3.4%	$64.6M+14.2%	$56.5M+41.0%	$40.1M-25.1%	$53.6M+172.5%	$19.7M-4.7%	$20.6M
SG&A Expenses	$22.1M+8.1%	$20.5M-6.5%	$21.9M-12.4%	$25.0M+13.3%	$22.0M-9.8%	$24.4M+355.9%	$5.4M+35.6%	$3.9M
Operating Income	$55.4M+39.3%	$39.8M+252.5%	$11.3M+7736.8%	$144K+100.6%	-$24.3M+70.7%	-$83.0M-1019.8%	$9.0M+556.2%	-$2.0M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$24.3M-4230.7%	-$560K+94.5%	-$10.1M+27.9%	-$14.0M-114.3%	-$6.5M-152.0%	$12.6M+446.5%	-$3.6M-226.5%	$2.9M
Net Income	$91.1M+77.9%	$51.2M+61.0%	$31.8M+28.8%	$24.7M+427.5%	-$7.5M+91.9%	-$93.0M-749.2%	$14.3M+558.5%	-$3.1M
EPS (Diluted)	$0.50+72.4%	$0.29+61.1%	$0.18-85.4%	$1.23+2560.0%	$-0.05+97.2%	$-1.77	$0.41+612.5%	$-0.08

ALAB Balance Sheet

Metric	FY24	FY23	FY22
Total Assets	$1.1B+437.2%	$196.3M	N/A
Current Assets	$1.0B+445.2%	$185.8M	N/A
Cash & Equivalents	$79.6M+76.4%	$45.1M-40.7%	$76.1M
Inventory	$43.2M+79.4%	$24.1M	N/A
Accounts Receivable	$38.8M+365.6%	$8.3M	N/A
Goodwill	N/A	N/A	N/A
Total Liabilities	$89.7M-69.5%	$294.0M	N/A
Current Liabilities	$86.5M+146.7%	$35.1M	N/A
Long-Term Debt	N/A	N/A	N/A
Total Equity	$964.8M+1087.5%	-$97.7M-14.5%	-$85.3M
Retained Earnings	-$208.8M-66.5%	-$125.4M	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$1.4B+10.2%	$1.3B+13.3%	$1.1B+6.4%	$1.1B+15.2%	$915.5M+5.9%	$864.9M+340.6%	$196.3M	N/A
Current Assets	$1.3B+9.3%	$1.2B+9.8%	$1.1B+6.2%	$1.0B+13.7%	$891.2M+4.3%	$854.4M+359.9%	$185.8M	N/A
Cash & Equivalents	$140.4M-13.5%	$162.3M+87.8%	$86.4M+8.6%	$79.6M-81.1%	$421.1M-39.5%	$696.1M+1443.5%	$45.1M+19.6%	$37.7M
Inventory	$51.7M-11.8%	$58.6M+14.8%	$51.1M+18.1%	$43.2M+51.2%	$28.6M-3.4%	$29.6M+22.7%	$24.1M	N/A
Accounts Receivable	$42.9M+76.4%	$24.3M-65.1%	$69.8M+79.8%	$38.8M+74.6%	$22.2M+32.7%	$16.8M+101.0%	$8.3M	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$129.5M-4.6%	$135.7M+69.3%	$80.1M-10.7%	$89.7M+27.7%	$70.3M+25.2%	$56.1M-80.9%	$294.0M	N/A
Current Liabilities	$101.0M-5.1%	$106.4M+37.7%	$77.3M-10.7%	$86.5M+35.1%	$64.1M+40.6%	$45.6M+30.0%	$35.1M	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.3B+12.0%	$1.1B+9.0%	$1.0B+8.0%	$964.8M+14.1%	$845.3M+4.5%	$808.8M+927.8%	-$97.7M+16.2%	-$116.6M
Retained Earnings	-$34.6M+72.5%	-$125.8M+28.9%	-$177.0M+15.2%	-$208.8M+7.6%	-$225.9M-3.5%	-$218.4M-74.2%	-$125.4M	N/A

ALAB Cash Flow Statement

Metric	FY24	FY23	FY22
Operating Cash Flow	$136.7M+1174.8%	-$12.7M+64.6%	-$35.9M
Capital Expenditures	$34.2M+1140.3%	$2.8M-28.7%	$3.9M
Free Cash Flow	$102.4M+761.8%	-$15.5M+61.1%	-$39.8M
Investing Cash Flow	-$757.6M-4162.7%	-$17.8M+80.4%	-$90.6M
Financing Cash Flow	$655.8M+130745.0%	-$502K-100.3%	$151.7M
Dividends Paid	N/A	N/A	N/A
Share Buybacks	$1.1M+407.6%	$210K-32.9%	$313K

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	$78.2M-42.3%	$135.4M+1188.7%	$10.5M-73.5%	$39.7M+33.2%	$29.8M+716.3%	$3.7M-74.6%	$14.4M+4411.1%	-$334K
Capital Expenditures	$12.3M+507.7%	$2.0M-55.4%	$4.5M-70.6%	$15.4M+1266.8%	-$1.3M-138.7%	$3.4M+238.7%	$1.0M+37.4%	$736K
Free Cash Flow	$65.9M-50.6%	$133.3M+2135.4%	$6.0M-75.4%	$24.3M-14.9%	$28.5M+12395.2%	$228K-98.3%	$13.4M+1351.2%	-$1.1M
Investing Cash Flow	-$101.0M-58.6%	-$63.7M-1516.6%	-$3.9M+95.7%	-$91.4M+69.8%	-$302.5M-7015.3%	-$4.3M+28.7%	-$6.0M+89.4%	-$56.3M
Financing Cash Flow	$952K-79.9%	$4.7M+1127.2%	$386K-93.2%	$5.7M+341.2%	-$2.3M-100.4%	$651.6M+61627.7%	-$1.1M-264.4%	$644K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ALAB Financial Ratios

Metric	FY24	FY23	FY22
Gross Margin	76.4%+7.4pp	68.9%-4.5pp	73.5%
Operating Margin	-29.3%-3.8pp	-25.5%+49.9pp	-75.4%
Net Margin	-21.1%+1.6pp	-22.7%+50.4pp	-73.0%
Return on Equity	N/A	N/A	N/A
Return on Assets	-7.9%+5.5pp	-13.4%	N/A
Current Ratio	11.71+6.4	5.30	N/A
Debt-to-Equity	0.09+3.1	-3.01	N/A
FCF Margin	25.9%+39.2pp	-13.4%+36.4pp	-49.8%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	76.3%+0.4pp	75.8%+0.9pp	74.9%+0.9pp	74.0%-3.9pp	77.9%+0.5pp	77.4%+0.2pp	77.3%+1.1pp	76.1%
Operating Margin	24.0%+3.3pp	20.7%+13.6pp	7.1%+7.0pp	0.1%+31.8pp	-31.7%+95.5pp	-127.1%-145.0pp	17.9%+23.2pp	-5.3%
Net Margin	39.5%+12.8pp	26.7%+6.7pp	20.0%+2.4pp	17.5%+27.3pp	-9.8%+132.7pp	-142.5%-170.9pp	28.4%+36.8pp	-8.5%
Return on Equity	7.2%+2.6pp	4.5%+1.5pp	3.0%+0.5pp	2.6%	N/A	N/A	N/A	N/A
Return on Assets	6.5%+2.5pp	4.0%+1.2pp	2.8%+0.5pp	2.3%+3.2pp	-0.8%+9.9pp	-10.8%-18.1pp	7.3%	N/A
Current Ratio	12.78+1.7	11.10-2.8	13.92+2.2	11.71-2.2	13.91-4.8	18.74+13.4	5.30	N/A
Debt-to-Equity	0.10-0.0	0.12+0.0	0.08-0.0	0.090.0	0.08+0.0	0.07+3.1	-3.01	N/A
FCF Margin	28.6%-40.9pp	69.5%+65.7pp	3.7%-13.5pp	17.2%-19.9pp	37.1%+36.7pp	0.4%-26.2pp	26.5%+29.4pp	-2.9%

Similar Companies

Monolithic Power MPWR

$56.3B

Microchip Technology Inc. MCHP

$42.7B

CREDO TECHNOLOGY GROUP HOLDING CRDO

$22.0B

Nxp Semiconduct NXPI

$61.0B

Marvell Technology Inc MRVL

$66.3B

Frequently Asked Questions

What is ASTERA LABS INC's annual revenue?

ASTERA LABS INC (ALAB) reported $396.3M in total revenue for fiscal year 2024. This represents a 242.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ASTERA LABS INC's revenue growing?

ASTERA LABS INC (ALAB) revenue grew by 242.2% year-over-year, from $115.8M to $396.3M in fiscal year 2024.

Is ASTERA LABS INC profitable?

No, ASTERA LABS INC (ALAB) reported a net income of -$83.4M in fiscal year 2024, with a net profit margin of -21.1%.

What is ASTERA LABS INC's earnings per share (EPS)?

ASTERA LABS INC (ALAB) reported diluted earnings per share of $-0.64 for fiscal year 2024. This represents a 9.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is ASTERA LABS INC's EBITDA?

ASTERA LABS INC (ALAB) had EBITDA of -$112.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is ASTERA LABS INC's gross margin?

ASTERA LABS INC (ALAB) had a gross margin of 76.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is ASTERA LABS INC's operating margin?

ASTERA LABS INC (ALAB) had an operating margin of -29.3% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is ASTERA LABS INC's net profit margin?

ASTERA LABS INC (ALAB) had a net profit margin of -21.1% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is ASTERA LABS INC's free cash flow?

ASTERA LABS INC (ALAB) generated $102.4M in free cash flow during fiscal year 2024. This represents a 761.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is ASTERA LABS INC's operating cash flow?

ASTERA LABS INC (ALAB) generated $136.7M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are ASTERA LABS INC's total assets?

ASTERA LABS INC (ALAB) had $1.1B in total assets as of fiscal year 2024, including both current and long-term assets.

What are ASTERA LABS INC's capital expenditures?

ASTERA LABS INC (ALAB) invested $34.2M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How much does ASTERA LABS INC spend on research and development?

ASTERA LABS INC (ALAB) invested $200.8M in research and development during fiscal year 2024.

Does ASTERA LABS INC buy back shares?

Yes, ASTERA LABS INC (ALAB) spent $1.1M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

How many shares does ASTERA LABS INC have outstanding?

ASTERA LABS INC (ALAB) had 162M shares outstanding as of fiscal year 2024.

What is ASTERA LABS INC's current ratio?

ASTERA LABS INC (ALAB) had a current ratio of 11.71 as of fiscal year 2024, which is generally considered healthy.

What is ASTERA LABS INC's debt-to-equity ratio?

ASTERA LABS INC (ALAB) had a debt-to-equity ratio of 0.09 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is ASTERA LABS INC's return on assets (ROA)?

ASTERA LABS INC (ALAB) had a return on assets of -7.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is ASTERA LABS INC's Piotroski F-Score?

ASTERA LABS INC (ALAB) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ASTERA LABS INC's earnings high quality?

ASTERA LABS INC (ALAB) has an earnings quality ratio of -1.64x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is ASTERA LABS INC?

ASTERA LABS INC (ALAB) scores 80 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.